Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan · Delayed Price · Currency is TWD 29.80
-0.05 (-0.17%)
Jan 22, 2026, 1:30 PM CST
TPEX:4111 Market Cap
TPEX:4111 has a market cap or net worth of 1.79 billion as of January 22, 2026. Its market cap has increased by 14.81% in one year.
Market Cap
1.79B
Enterprise Value
1.39B
Revenue
1.36B
Ranking
n/a
PE Ratio
10.87
Stock Price
29.80
Market Cap Chart
Since April 11, 2006, TPEX:4111's market cap has increased from 735.73M to 1.79B, an increase of 142.75%. That is a compound annual growth rate of 4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.79B | 1.36% |
| Dec 31, 2025 | 1.76B | 11.23% |
| Dec 31, 2024 | 1.58B | 4.32% |
| Dec 29, 2023 | 1.52B | -1.66% |
| Dec 30, 2022 | 1.54B | 17.32% |
| Dec 30, 2021 | 1.32B | -3.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Lin BioScience | 31.15B |